Share This

Related Topics News -

     
 Title only   |   Print 
     
來凱醫藥治療乳腺癌藥物III期臨床試驗完成首例患者入組

2024-05-30T  
來凱醫藥-B前列腺癌藥物獲美國FDA批准III期臨床試驗

2024-05-23T  
來凱醫藥-B獲內地批准治療肥胖症患者新藥臨床試驗

2024-05-10T  
來凱醫藥-B午後曾抽升76% 治療肥胖新藥獲美國FDA批准臨床試驗

2024-04-15T  
來凱醫藥:美國批准LAE102進行用於治療肥胖症患者IND

2024-04-15T  
《公司業績》來凱醫藥-B全年虧損收窄至3.69億元人民幣

2024-03-26T  

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.